Missouri Judge Timothy Boyer approved a $7 billion nationwide settlement Friday over agrochemical company Bayer’s popular weedkiller Roundup, which plaintiffs alleged caused a form of cancer called non-Hodgkin lymphoma.
The multi-billion dollar settlement will be paid out over the course of 21 years to thousands of plaintiffs who claimed that the company should have warned people that its popular weed killer Roundup could cause cancer.
The settlement applies to patients who are already sick and those who become diagnosed with non-Hodgkin lymphoma in future years, if they were exposed to the product before the settlement was proposed in February.
Participants could get an average of between $10,000 and $165,000, depending on how they used the product, how old they were when diagnosed and the severity of their illness, according to the Associated Press.
“Today’s final approval order delivers guaranteed compensation to Roundup cancer victims who have waited more than a decade for justice,” said Christopher A. Seeger, a court-appointed counsel for cancer patients in the case.
Bayer has denied that its product causes cancer but has changed the formula for its Roundup version sold to residential users by removing glyphosate. But approximately 200,000 Roundup-related claims have been made against the company, and many have come from people who used it on their lawns and gardens.